First human tests begin for promising new skin disease treatment

This is the first time researchers are testing the experimental drug BG-A3004 in people. The study aims to check if the drug is safe and how it behaves in the body, first in healthy volunteers and then in patients with immune-related skin conditions like alopecia areata, lichen planus, and vitiligo. Participants will receive either the drug or a placebo, and researchers will monitor them for side effects and how the drug moves through their system.